Form 8-K - Current report:
SEC Accession No. 0000950170-25-095167
Filing Date
2025-07-11
Accepted
2025-07-11 07:28:28
Documents
64
Period of Report
2025-07-11
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K kpti-20250711.htm   iXBRL 8-K 72259
2 EX-99.1 kpti-ex99_1.htm EX-99.1 76791
3 GRAPHIC kpti-ex99_1s1.jpg GRAPHIC 171181
4 GRAPHIC kpti-ex99_1s2.jpg GRAPHIC 813148
5 GRAPHIC kpti-ex99_1s3.jpg GRAPHIC 428374
6 GRAPHIC kpti-ex99_1s4.jpg GRAPHIC 426698
7 GRAPHIC kpti-ex99_1s5.jpg GRAPHIC 450565
8 GRAPHIC kpti-ex99_1s6.jpg GRAPHIC 484470
9 GRAPHIC kpti-ex99_1s7.jpg GRAPHIC 362719
10 GRAPHIC kpti-ex99_1s8.jpg GRAPHIC 607780
11 GRAPHIC kpti-ex99_1s9.jpg GRAPHIC 472365
12 GRAPHIC kpti-ex99_1s10.jpg GRAPHIC 423401
13 GRAPHIC kpti-ex99_1s11.jpg GRAPHIC 425532
14 GRAPHIC kpti-ex99_1s12.jpg GRAPHIC 428846
15 GRAPHIC kpti-ex99_1s13.jpg GRAPHIC 377970
16 GRAPHIC kpti-ex99_1s14.jpg GRAPHIC 387815
17 GRAPHIC kpti-ex99_1s15.jpg GRAPHIC 284090
18 GRAPHIC kpti-ex99_1s16.jpg GRAPHIC 340249
19 GRAPHIC kpti-ex99_1s17.jpg GRAPHIC 296369
20 GRAPHIC kpti-ex99_1s18.jpg GRAPHIC 420306
21 GRAPHIC kpti-ex99_1s19.jpg GRAPHIC 405050
22 GRAPHIC kpti-ex99_1s20.jpg GRAPHIC 416550
23 GRAPHIC kpti-ex99_1s21.jpg GRAPHIC 590964
24 GRAPHIC kpti-ex99_1s22.jpg GRAPHIC 409141
25 GRAPHIC kpti-ex99_1s23.jpg GRAPHIC 128370
26 GRAPHIC kpti-ex99_1s24.jpg GRAPHIC 390929
27 GRAPHIC kpti-ex99_1s25.jpg GRAPHIC 316936
28 GRAPHIC kpti-ex99_1s26.jpg GRAPHIC 123461
29 GRAPHIC kpti-ex99_1s27.jpg GRAPHIC 356207
30 GRAPHIC kpti-ex99_1s28.jpg GRAPHIC 269088
31 GRAPHIC kpti-ex99_1s29.jpg GRAPHIC 116160
32 GRAPHIC kpti-ex99_1s30.jpg GRAPHIC 552252
33 GRAPHIC kpti-ex99_1s31.jpg GRAPHIC 551040
34 GRAPHIC kpti-ex99_1s32.jpg GRAPHIC 334124
35 GRAPHIC kpti-ex99_1s33.jpg GRAPHIC 413049
36 GRAPHIC kpti-ex99_1s34.jpg GRAPHIC 472255
37 GRAPHIC kpti-ex99_1s35.jpg GRAPHIC 475634
38 GRAPHIC kpti-ex99_1s36.jpg GRAPHIC 345827
39 GRAPHIC kpti-ex99_1s37.jpg GRAPHIC 576928
40 GRAPHIC kpti-ex99_1s38.jpg GRAPHIC 304951
41 GRAPHIC kpti-ex99_1s39.jpg GRAPHIC 478941
42 GRAPHIC kpti-ex99_1s40.jpg GRAPHIC 127477
43 GRAPHIC kpti-ex99_1s41.jpg GRAPHIC 445487
44 GRAPHIC kpti-ex99_1s42.jpg GRAPHIC 493691
45 GRAPHIC kpti-ex99_1s43.jpg GRAPHIC 454977
46 GRAPHIC kpti-ex99_1s44.jpg GRAPHIC 408043
47 GRAPHIC kpti-ex99_1s45.jpg GRAPHIC 352247
48 GRAPHIC kpti-ex99_1s46.jpg GRAPHIC 330243
49 GRAPHIC kpti-ex99_1s47.jpg GRAPHIC 366367
50 GRAPHIC kpti-ex99_1s48.jpg GRAPHIC 303114
51 GRAPHIC kpti-ex99_1s49.jpg GRAPHIC 322730
52 GRAPHIC kpti-ex99_1s50.jpg GRAPHIC 415396
53 GRAPHIC kpti-ex99_1s51.jpg GRAPHIC 568549
54 GRAPHIC kpti-ex99_1s52.jpg GRAPHIC 502168
55 GRAPHIC kpti-ex99_1s53.jpg GRAPHIC 507641
  Complete submission text file 0000950170-25-095167.txt   29521706

Data Files

Seq Description Document Type Size
56 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT kpti-20250711.xsd EX-101.SCH 30858
67 EXTRACTED XBRL INSTANCE DOCUMENT kpti-20250711_htm.xml XML 4511
Mailing Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459
Business Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459 617-658-0600
Karyopharm Therapeutics Inc. (Filer) CIK: 0001503802 (see all company filings)

EIN.: 263931704 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36167 | Film No.: 251117501
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)